5F-PCN

5F-PCN

Systematic (IUPAC) name
1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-pyrrolo[3,2-c]pyridine-3-carboxamide
Clinical data
Legal status	CA: Schedule II
Chemical data
Formula	C23H22FN3O
Molecular mass	375.4 g/mol
SMILES O=C(NC1=C(C=CC=C2)C2=CC=C1)C3=CN(CCCCCF)C4=C3C=NC=C4
InChI InChI=1S/C23H22FN3O/c24-12-4-1-5-14-27-16-20(19-15-25-13-11-22(19)27)23(28)26-21-10-6-8-17-7-2-3-9-18(17)21/h2-3,6-11,13,15-16H,1,4-5,12,14H2,(H,26,28) Key:BRRZRRZUERBDQL-UHFFFAOYSA-N

5F-PCN (also known as 5-F-MN-21) is an azaindole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB₁ receptor and has been sold online as a designer drug. It is closely related to NNE1. Given the known metabolic liberation (and presence as an impurity) of amantadine in the related compound APINACA, it is suspected that metabolic hydrolysis of the amide group of 5F-PCN may release 1-naphthylamine, a known carcinogen.

Legal status

Sweden's public health agency suggested to classify 5F-PCN as hazardous substance on November 10, 2014.

See also

• 5F-NNE1
• AM-2201
• APICA
• CUMYL-PICA
• JWH-018
• NM-2201
• SDB-005